company background image
NPCE logo

NeuroPace NasdaqGM:NPCE Stock Report

Last Price

US$7.80

Market Cap

US$204.1m

7D

12.6%

1Y

7.6%

Updated

06 Nov, 2024

Data

Company Financials +

NeuroPace, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NeuroPace
Historical stock prices
Current Share PriceUS$7.80
52 Week HighUS$18.15
52 Week LowUS$5.45
Beta1.78
11 Month Change16.77%
3 Month Change9.24%
1 Year Change7.59%
33 Year Change-50.63%
5 Year Changen/a
Change since IPO-68.75%

Recent News & Updates

NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch

Aug 03
NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch

Recent updates

NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch

Aug 03
NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch

Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?

Apr 12
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?

NeuroPace: Picking Up The Pace

Feb 25

Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge

Jan 22
Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge

NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company

Apr 17
NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company

NeuroPace announces U.S. distribution agreement with DIXI Medical

Aug 11

NeuroPace EPS misses by $32.45, beats on revenue; issues guidance

Jun 03

Shareholder Returns

NPCEUS Medical EquipmentUS Market
7D12.6%1.1%2.3%
1Y7.6%29.2%35.1%

Return vs Industry: NPCE underperformed the US Medical Equipment industry which returned 27.5% over the past year.

Return vs Market: NPCE underperformed the US Market which returned 31.5% over the past year.

Price Volatility

Is NPCE's price volatile compared to industry and market?
NPCE volatility
NPCE Average Weekly Movement9.8%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.2%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

Stable Share Price: NPCE's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: NPCE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1997179Joel Beckerwww.neuropace.com

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.

NeuroPace, Inc. Fundamentals Summary

How do NeuroPace's earnings and revenue compare to its market cap?
NPCE fundamental statistics
Market capUS$204.09m
Earnings (TTM)-US$29.90m
Revenue (TTM)US$71.82m

3.2x

P/S Ratio

-7.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NPCE income statement (TTM)
RevenueUS$71.82m
Cost of RevenueUS$18.56m
Gross ProfitUS$53.26m
Other ExpensesUS$83.15m
Earnings-US$29.90m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 12, 2024

Earnings per share (EPS)-1.02
Gross Margin74.15%
Net Profit Margin-41.63%
Debt/Equity Ratio597.0%

How did NPCE perform over the long term?

See historical performance and comparison